Cloning and expression of PMI1945 involved in iron acquisition as a promising vaccine candidate against Proteus mirabilis

Autor: B Kavehei, M Habibi, S Sari, MR Asadi Karam

Publikováno v: Vaccine Research, Vol 5, Iss 1, Pp 14-18 (2018)

Introduction: Proteus mirabilis is one of the common pathogens of urinary tract infections. Iron scavenger receptors from P. mirabilis are considered as important virulence factors of this strain and have the properties of an ideal vaccine candidate.

Externí odkaz: https://doaj.org/article/24a17f5a8fa84af4a80b326cda1d22e5

Bioinformatics analysis and expression of a truncated form of Proteus mirabilis Pta protein as a novel vaccine target against urinary tract infection

Autor: E Choubini, MR Asadi Karam, A Khorshidi, M Habibi, A Ghasemi, S Bouzari

Publikováno v: Vaccine Research, Vol 3, Iss 3, Pp 68-73 (2016)

Introduction: Pathogenic strains of Proteus mirabilis have important roles in urinary tract infection. Proteus toxic agglutinin (Pta) is amongst the most important virulence factors of P. mirabilis. This protein has a conserved sequence present in al

Externí odkaz: https://doaj.org/article/9153285a79a344e4b7381ed8b47d6013

Immunostimulatory chimeric protein encapsulated in gelatin nanoparticles elicits protective immunity against Pseudomonas aeruginosa respiratory tract infection.

Autor: Parvaei M; Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran., Habibi M; Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran., Shahbazi S; Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran., Babaluei M; National Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran., Farokhi M; National Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran. Electronic address: m_farokhi@pasteur.ac.ir., Asadi Karam MR; Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran. Electronic address: m_asadi@pasteur.ac.ir.

Publikováno v: International journal of biological macromolecules [Int J Biol Macromol] 2024 Oct; Vol. 277 (Pt 1), pp. 133964. Date of Electronic Publication: 2024 Jul 17.

In silico and in vivo Investigations of the Immunoreactivity of Klebsiella pneumoniae OmpA Protein as a Vaccine Candidate

Autor: Shahbazi S; Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran., Badmasti F; Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran., Habibi M; Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran., Sabzi S; Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran., Noori Goodarzi N; Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran., Farokhi M; National Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran., Asadi Karam MR; Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran.

Publikováno v: Iranian biomedical journal [Iran Biomed J] 2024 Jul 01; Vol. 28 (4), pp. 156-67. Date of Electronic Publication: 2024 Jul 01.

Design and computational analysis of an effective multi-epitope vaccine candidate using subunit B of cholera toxin as a build-in adjuvant against urinary tract infections.

Autor: Rezaei M; Molecular Biology Department, Pasteur institute of Iran, Tehran, Iran., Habibi M; Molecular Biology Department, Pasteur institute of Iran, Tehran, Iran., Ehsani P; Molecular Biology Department, Pasteur institute of Iran, Tehran, Iran., Asadi Karam MR; Molecular Biology Department, Pasteur institute of Iran, Tehran, Iran., Bouzari S; Molecular Biology Department, Pasteur institute of Iran, Tehran, Iran.

Publikováno v: BioImpacts : BI [Bioimpacts] 2024; Vol. 14 (1), pp. 27513. Date of Electronic Publication: 2023 Aug 05.